SCHEMBL31748782

SCHEMBL31748782

COc1ccccc1C(=O)Nc1ccc2nc(-c3ccccc3F)[nH]c2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR2E3 Q9Y5X4 4/20 0.57
▸ FOXO1 Q12778 1/20 0.53
▸ NPC1 O15118 2/20 0.52
▸ RAB9A P51151 2/20 0.52
▸ HSP90AA1 P07900 1/20 0.52
▸ PKM P14618 1/20 0.52
▸ PAX8 Q06710 1/20 0.52
▸ MAPT P10636 4/20 0.52
▸ TP53 P04637 2/20 0.52
▸ KMT2A Q03164 3/20 0.52
▸ CYP2C9 P11712 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52
▸ KCNK3 O14649 1/20 0.51
▸ KCNK9 Q9NPC2 1/20 0.51
▸ POLB P06746 2/20 0.51
▸ AMY1A P0DUB6 1/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ RXFP1 Q9HBX9 1/20 0.51
▸ KDM4E B2RXH2 2/20 0.50
▸ HDAC6 Q9UBN7 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26597190 1.00 NR2E3 (0.57) NR2E3FOXO1NPC1RAB9AHSP90AA1
SCHEMBL26597196 0.87 NR2E3 (0.63) NR2E3NPC1RAB9AMAPTKMT2A
SCHEMBL31748608 0.87 NR2E3 (0.63) NR2E3NPC1RAB9AMAPTKMT2A
SCHEMBL31748600 0.84 NR2E3 (0.62) NR2E3FOXO1NPC1RAB9AMAPT
SCHEMBL26597175 0.84 NR2E3 (0.62) NR2E3FOXO1NPC1RAB9AMAPT
SCHEMBL31748612 0.82 MAPT (0.63) NR2E3MAPTKMT2ACYP2C9CYP2C19
SCHEMBL26597183 0.82 MAPT (0.63) NR2E3MAPTKMT2ACYP2C9CYP2C19
SCHEMBL31748716 0.80 ALDH1A1 (0.68) NR2E3FOXO1MAPTTP53KMT2A
SCHEMBL30667673 0.80 ALDH1A1 (0.68) NR2E3FOXO1MAPTTP53KMT2A
SCHEMBL26597195 0.80 ALDH1A1 (0.68) NR2E3FOXO1MAPTTP53KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250388551-A1 COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS UNIV PARIS CITE (FR) 2025-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250388551-A1 COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS CXCL10, CCR10, IL2 NR2E3 2814/4885FOXO1 771/4885NPC1 890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback